ArticleFrontiers in oncology2023

CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells.

Ivan David Lozada-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.